Clinical Trials
- Infectious Disease, Immune System
Multicenter, Open Label, Phase 3 Trial of ATA129 for Solid Organ Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)
- GenderBoth
- Date03/12/2018
- Children's Health, Diabetes, Genetics, Heart/Cardiovascular, Obesity & Weight Management, Endocrine System
Prevalence of Carbohydrate Intolerance in Lean and Obese Children
- Ages8 years - 18 years
- GenderBoth
- Date09/24/1999
- Brain, Spinal Cord & Nervous System, Vision/Eye, Liver
Wilson Disease Registry
- GenderBoth
- Date11/16/2017